A former director and chief scientific officer of bankrupt COVID-19 drug developer Humanigen (OTC:HGENQ) has been arrested in Switzerland on charges that he engaged in insider trading and 10b5-1 plan abuses.

Dale Chappell is accused of avoiding more than $38M in